partners events and mentions.jpeg

Regional Events and Mentions

By honoring researchers, engineers, and data scientists, we leverage regional convergence to place our community in the context of international breakthroughs for human health.

If you have an event, program, or regional news to share, 
please email




Charles River - 2nd Annual World Congress: Lessons Learned from Rare Disease and Personalized Medicine Approaches
September 17-18
, 2018; Cambridge, MA
More Information

Charles River is proud to host the 2nd Annual World Congress: Lessons Learned from Rare Disease and Personalized Medicine Approaches on September 17-18 at the Royal Sonesta hotel in Cambridge, MA.

The conference agenda is a mix of presentations, panel discussions and short technology demonstrations that will cover a wide range of strategies for successful drug discovery. While the focus of the conference is rare diseases and personalized medicine across various therapeutic areas, there will be a broader discussion around drug discovery approaches and innovative therapeutic modalities that are being employed in the rare disease space.

SoPE NYC: Blockchain in Healthcare - Boom, Bogus, or Bust!
September 26
, 2018; New York, NY
More Information

Blockchain in it really a revolution? Is it anything more than Bitcoin? Heralded as everything from a complete scam to the most revolutionary technology since the internet, join us as we discuss the practical applications of blockchain in healthcare, its limitations, and the challenges it faces for widespread adoption within the healthcare system.

Innovations in Dermatological Sciences: Future of Dermatologicals & Cosmeceuticals
October 8-9
, 2018; Iselin, NJ
More Information

Topicals & skin applied-products will likely remain the cornerstone of treatment for skin diseases and for cosmetic uses (sunscreens, anti-aging, etc.). Conference attendees will gain insights into novel approaches for formulating & evaluating skin products, using novel skin models & methods of skin visualization to monitor transport of actives into the skin as well as use of 3D printing of skin and dermal products. Impact of these new approaches on regulatory agencies will also be discussed.

Sartorius Stedim Biotech - Science On Tap Product Showcase
October 11, 2018; Elmsford, NY
More Information

Learn about Sartorius upstream and downstream technology portfolios.
Mingle with your local Sartorius subject matter experts to discuss your specific process or application issues.
Network with your industry peers and like-minded professionals.

NEXT 2018
November 15
, 2018; Liverpool, NY
More Information

It all starts here. Our dynamic program boasts two world-class keynotes as well as interactive workshops on Law & Commercialization, Manufacturing Excellence and Biotech Innovation. Get a first-hand look at NEXT generation opportunities, discoveries and products at our Technology Showcase. And stick around for our Networking Reception to connect with other Central New York companies, researchers, manufacturers and investors.

13th Annual New England Venture Summit
December 12, 2018; Randolph, MA
More Information
Register using Discount Code WBPVIP

The 13th annual New England Venture Summit, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of venture backed, emerging and early stage companies, university researchers, incubators and premier service providers.

Whether you are an investor seeking access to new deals, or founder and/or CEO of a new venture looking for funding, visibility and growth, The 2018 New England Venture Summit is one event you won't want to miss.

ACRP (Association of Clinical Research Professionals) 2019
April 12-15, 2019; Nashville, TN
Proposal Deadline: August 10, 2018
More Information

Help advance the clinical research community by sharing best practices, case studies, practical tips and expertise at ACRP 2019. Submit your proposal to speak and be recognized as a leader, raise your professional profile, and expand your network.Session proposals are sought for one-hour breakout sessions, two-hour ‘masters series’ sessions, four-hour pre-conference workshops, and eight-hour workshops.

ACRP 2019 brings the clinical research community together to learn, connect and explore opportunities to improve operations. Here are a few other highlights of what's in store for 2019:

  • 60 Educational Sessions Designed to Improve Operations and Build Professional Competence
  • 125+ Thought Leaders and Session Presenters
  • 1,200+ Members of the Clinical Research Community
  • 100+ Leading-Edge Suppliers and Solutions Providers


Novo Holdings REPAIR Impact Fund
Proposal Deadline: October 11, 2018
More Information

The Novo Holdings REPAIR Impact Fund will be open for proposals from companies located in the United States and Canada developing novel anti-infectives from September 4 until October 11. The templates will resemble those used in the current European proposal round and will be up soon here.

What we are looking for: The REPAIR Impact Fund invests in start-ups, early-stage companies and corporate spin-outs in Europe and the United States. Our philosophy is to support ambitious programmes addressing antibiotic resistance through a broad range of therapeutic modalities.

FFMI fastPACE; Train-the-Trainer for fastPACE
September 20-21: University of Michigan Workshop
September 28: Conference Call 3-4:30 p
October 5: Conference Call 3-4:30 p
October 12: Conference Call 3-4:30 p
October 19: Live Stream/University of Michigan 12-5 p
More Information

Starting September 2018, FFMI will launch its 9th cohort of this 4-week biomedical commercialization and innovation course designed for the busy medical academician with an early stage biomedical product idea. This course blends in-person and online education to help faculty researchers and clinicians prepare a successful business case for funding and partnerships.

In parallel to fastPACE, participating CTSA organizations will have the opportunity to observe our expert teaching team and learn how to launch this program at their home institutions providing their biomedical faculty with the knowledge and tools necessary to navigate the initial process of innovation and commercialization. This 4-week course is a hands-on collaborative learning experience.

Announcing Special Issue on Security and Privacy for Healthcare Technologies
Deadline for manuscript submissions: November 1, 2018
More Information

The MDPI Journal on Cybersecurity and Privacy is a journal devoted to providing a venue for articles and community engagement that will advance the state of the art in security and privacy research and practice. Towards this end, the journal will run a Special Issue on “Security and Privacy for Healthcare Technologies”. The Special Issue aims to attract a combination of research articles that convey new security and privacy technologies, educational survey articles that help advance the adoption and practice of cybersecurity technologies by the broader healthcare community, and informative articles that cross the boundaries between public and legal aspects related to cybersecurity and privacy in healthcare.

The goal of this Special Issue is to strengthen the relationship between the security/privacy research and development community and those in the healthcare and medical practice communities, with the ultimate objective being to lead to better solutions and practice to protect patients and their private information.

News and Articles

Antonio Biancardi's company, DataForm Software, migrates to Microsoft Azure
Antonio is on our Board of Directors
August 29, 2018
More Information

Recently recognized by CIO Magazine as a leader in corporate finance technology, DataForm Software ( announces the migration of its flagship cloud-based product Planet Life Cycle – a robust work management application – to Microsoft Azure. Planet is a team-centric, enterprise work management system that merges strategic and financial planning with execution.

FDA Public Workshop: “Development of Non-Traditional Therapies for Bacterial Infections."
August 26
, 2018
More Information

The Food and Drug Administration held a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections." Two companies were invited by FDA to provide industry perspectives, Contrafect and Merck, the two leaders in the industry  developing Non-Traditional Therapies for Bacterial Infections. 

Target Health’s Senior Director of Regulatory Affairs, Mary Shatzoff, had the privilege of joining Contrafect’s Chief Medical Officer, Cara Cassino, and Executive Director of Clinical Development and Medical Affairs, Alena Jandourek. Dr. Cassino delivered an exciting summary of the progress Contrafect has made with their development program for CF-301 (exebacase). The workshop was a tremendous success and the FDA has agreed to continue these initiatives to advance this important work.

NJII Health IT Connections enters 9th round
August 24
, 2018
More Information

New Jersey Innovation Institute, an NJIT corporation, has helped more than 90 companies through its Health IT Connections program and now, NJII is putting out the call for new applicants.

Entering its fifth year, Health IT Connections works to grow the industry through the support of growth-stage health IT entrepreneurs via training, mentoring and building connections to new customers, strategic partners and suppliers.

ContraFect prices $10M public offering of common stock
July 30, 2018
More Information

ContraFect Corp., a Yonkers biotechnology company, announced the pricing of its underwritten public offering of 5 million shares of common stock at $2.00 per share. Proceeds from the offering will be $10 million.

ContraFect also granted the underwriters a 30-day option to purchase up to an additional 750,000 shares. The offering is expected to close on July 31, subject to customary closing conditions.

Profectus BioSciences leases labs at Pearl River campus
May 24, 2018
More Information

Profectus BioSciences, a vaccine maker that focuses on infectious diseases and associated cancers, has leased 39,455 square feet of space for labs and offices at the former Pfizer research campus in Pearl River.

The landlord, Los Angeles-based Industrial Realty Group (IRG), announced the new tenant and a new name for the campus, the New York Center for Innovation.